In Title VII actions, plaintiffs have a limited amount of time to file a charge of discrimination (or a court can dismiss the ...

Ackerman v. Pink asks how much of a written history can be claimed as proprietary by the author of that history. The answer: ...

On March 10, 2025, a federal judge in Maryland clarified the scope of the nationwide preliminary injunction that enjoins key ...

Overview Shortly after taking office, President Donald Trump issued two executive orders (EOs) targeting diversity, equity, ...

The FCC’s TCPA one-to-one consent rule still has the faintest of pulses as the NCLC continues to struggle to bring it back to ...

It is well-settled that under Article III of the Constitution, United States federal courts are limited to trying “cases and ...

SuperValu, Inc. (SuperValu), a grocery store chain that operates in-store pharmacies, was cleared of liability by a Central ...

Judge Horan held in Edwards v. First Trust Portfolios LP that a Dodd-Frank whistleblower retaliation plaintiff is not ...

Background: ImmunoGen’s Patent Application & Dispute. In 2014, ImmunoGen, Inc. (Immunogen) filed U.S. Patent Application No.

FinCEN and the Department of the Treasury both provided updates this week regarding the Corporate Transparency Act.

Right of erasure (or “right to be forgotten”) has been selected by the European Data Protection Board as its priority ...

On February 28, the US Patent and Trademark Office (USPTO) rescinded former Director Kathi Vidal’s 2022 memorandum on ...